UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997

Journal of clinical oncology, 2007-03, Vol.25 (7), p.793-798

2007

Volltextzugriff (PDF)

Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations

Thrombosis and haemostasis, 2006-06, Vol.95 (6), p.924-930

Hussein, Mohamad A

2006

Volltextzugriff (PDF)

The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma

Mayo Clinic proceedings, 2005-12, Vol.80 (12), p.1568-1574

2005

Volltextzugriff (PDF)

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

The Journal of clinical investigation, 2007-10, Vol.117 (10), p.3107-3117

2007

Volltextzugriff (PDF)

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Blood, 2007-06, Vol.109 (11), p.5002-5010

2007

Volltextzugriff (PDF)

Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma

Mayo Clinic proceedings, 2006-07, Vol.81 (7), p.889-895

2006

Volltextzugriff (PDF)

Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study

BioMed research international, 2015-01, Vol.2015 (2015), p.1-11

2015

Volltextzugriff (PDF)

Bronchoscopic Diagnosis and Treatment of Primary Tracheobronchial Amyloidosis: A Retrospective Analysis from China

BioMed research international, 2017-01, Vol.2017 (2017), p.1-7

2017

Volltextzugriff (PDF)

Design and In Vitro Evaluation of a New Nano-Microparticulate System for Enhanced Aqueous-Phase Solubility of Curcumin

BioMed research international, 2013-01, Vol.2013 (2013), p.1-9

2013

Volltextzugriff (PDF)

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

British journal of haematology, 2003-08, Vol.122 (3), p.441-450

2003

Volltextzugriff (PDF)

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Blood, 2010-12, Vol.116 (26), p.5838-5841

2010

Volltextzugriff (PDF)

Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204)

Journal of clinical oncology, 2009-07, Vol.27 (21), p.3510-3517

2009

Volltextzugriff (PDF)

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Blood cancer journal (New York), 2018-07, Vol.8 (7), p.67-8, Article 67

2018

Volltextzugriff (PDF)

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

BioMed research international, 2017-01, Vol.2017 (2017), p.1-6

2017

Volltextzugriff (PDF)

Apoptosis of multiple myeloma

International journal of hematology, 2004-10, Vol.80 (3), p.224-231

2004

Volltextzugriff (PDF)

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Cancer, 2003-10, Vol.98 (8), p.1735-1744

2003

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma : A phase III multicenter randomized trial

Cancer, 2006-02, Vol.106 (4), p.848-858

2006

Volltextzugriff (PDF)

Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma

Leukemia & lymphoma, 2003-07, Vol.44 (7), p.1209-1214

2003

Volltextzugriff (PDF)

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

Blood, 2006-07, Vol.108 (1), p.403-403

2006

Volltextzugriff (PDF)

Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease

Cancer, 2004-08, Vol.101 (3), p.558-566

2004

Volltextzugriff (PDF)

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

Blood, 2011-09, Vol.118 (13), p.3525-3527

2011

Volltextzugriff (PDF)

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

British journal of haematology, 2004-05, Vol.125 (4), p.470-476

2004

Volltextzugriff (PDF)

Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628

Blood, 2004-12, Vol.104 (12), p.3520-3526

2004

Volltextzugriff (PDF)

A phase II trial of BAY 43‐9006 (sorafenib) (NSC‐724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1275-1283

2014

Volltextzugriff (PDF)

1 – 25 von 1.360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(901)
Mit Volltextzugriff
(856)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(646)
Life Sciences & Biomedicine
(386)
Humans
(226)
Technology
(220)
Engineering
(169)
Female
(116)
Male
(112)
Middle Aged
(81)
Engineering, Multidisciplinary
(77)
Adult
(75)
Physical Sciences
(75)
Aged
(68)
Oncology
(66)
Biological And Medical Sciences
(52)
Medical Sciences
(52)
Hematology
(49)
General & Internal Medicine
(47)
Engineering, Electrical & Electronic
(46)
Multiple Myeloma - Drug Therapy
(46)
Medicine, General & Internal
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997

Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations

The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma

Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study

Bronchoscopic Diagnosis and Treatment of Primary Tracheobronchial Amyloidosis: A Retrospective Analysis from China

Design and In Vitro Evaluation of a New Nano-Microparticulate System for Enhanced Aqueous-Phase Solubility of Curcumin

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204)

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

Apoptosis of multiple myeloma

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma : A phase III multicenter randomized trial

Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628

A phase II trial of BAY 43‐9006 (sorafenib) (NSC‐724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434

Suchergebnisse filtern